Strategic Partnerships Femasys has actively pursued partnerships with healthcare systems and clinics (UNC Health, UNC Rex Healthcare) and financing partners (CapexMD) to expand access to its fertility portfolio, signaling strong near-term sales opportunities through integrated OB/GYN networks and patient financing programs.

Expanded Commercial Reach Recent launches and deployments of FemaSeed Complete and the FemVue portfolio across U.S. OB/GYN practices, along with statewide rollouts, indicate ongoing channel expansion that sales teams can leverage to upsell to existing customers and recruit new clinic partners.

Financing Solutions Partnerships focused on dedicated financing for FemaSeed offerings suggest a growth path through patient access programs, enabling clinics to offer cost-effective fertility solutions and non-surgical birth control with improved affordability for patients.

Israel and Global Expansion Strategic alliance with AMI Technologies to introduce the fertility portfolio in Israel points to a clear international expansion track, presenting international BD opportunities with local distributors, regulatory partners, and healthcare providers.

Product Portfolio Focus A strong emphasis on non-surgical birth control and infertility delivery tools (FemBloc, FemaSeed, FemVue) combined with an office-based tissue sampling platform suggests cross-sell potential within clinics for multiple women’s health solutions, increasing average deal size per account.